-
1141
-
1142
-
1143
Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens
Published 2024-12-01Subjects: Get full text
Article -
1144
Improving CD3 bispecific antibody therapy in solid tumors using combination strategies
Published 2025-02-01Subjects: Get full text
Article -
1145
-
1146
-
1147
Limited preventive care among Medicaid enrollees with HIV in the US South
Published 2025-01-01Subjects: Get full text
Article -
1148
TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts
Published 2024-02-01“…The indirect and direct effects of the TGFβ vaccine on these cell subsets were evaluated by culturing M2 macrophages or fibroblasts with tumor-conditioned media or with T cells isolated from the spleen of mice treated with the TGFβ vaccine or a control vaccine, respectively. …”
Get full text
Article -
1149
Development of a multi-epitope chimeric vaccine in silico against Babesia bovis, Theileria annulata, and Anaplasma marginale using computational biology tools and reverse vaccinology approach.
Published 2025-01-01“…In this paper, we have used the process of reverse vaccinology to conduct a study in which we have developed a multi-epitope subunit chimeric vaccine against three protozoan parasites. We constructed three chimeric vaccine sequences from which only one chimeric vaccine construct was found to be an effective and efficient vaccine which is stable with high solubility and negative allergenicity. …”
Get full text
Article -
1150
Protection against SHIV-KB9 Infection by Combining rDNA and rFPV Vaccines Based on HIV Multiepitope and p24 Protein in Chinese Rhesus Macaques
Published 2012-01-01“…Developing an effective vaccine against HIV infection remains an urgent goal. …”
Get full text
Article -
1151
Intention to vaccinate against COVID-19 and adherence to non-pharmaceutical interventions against COVID-19 prior to the second wave of the pandemic in Uganda: a cross-sectional study
Published 2022-06-01“…Dissemination of accurate, safe and efficacious information about the vaccines is necessary to enhance vaccine uptake.…”
Get full text
Article -
1152
Identifying facilitators and barriers to culturally responsive communication for racial, ethnic, sexual, and gender minoritized patients when screened for COVID-19 vaccinations: A scoping review protocol.
Published 2023-01-01“…This scoping literature review aims to determine the current breadth of literature on culturally responsive communication (CRC) in regard to COVID-19 vaccination screening for historically excluded, or minoritized groups. …”
Get full text
Article -
1153
Defective antigen presentation by monocytes in ESRD patients not responding to hepatitis B vaccination: impaired HBsAg internalization and expression of ICAM-1 and HLA-DR/Ia molecules
Published 1995-01-01“…This study was undertaken to evaluate the monocyte function of uraemic non-responders to hepatitis B vaccination. Therefore, some parameters concerning antigen processing by monocytes (Mo) as antigen presenting cells (APC) were analysed. …”
Get full text
Article -
1154
Challenges with achieving and maintaining oral cholera vaccine coverage: insights from serial cross-sectional representative surveys in a cholera-endemic community in the Democratic Republic of the Congo
Published 2025-01-01“…Background We conducted three serial cross-sectional representative surveys after a mass cholera vaccination campaign in Uvira, Democratic Republic of the Congo to (1) estimate the vaccination coverage and explore heterogeneity by geographic and demographic factors; (2) examine barriers and facilitators of vaccine uptake and (3) describe the changes in coverage over time and predict future coverage.Methods We collected data on sociodemographics, self-reported vaccination status, population movement and knowledge, attitudes and behaviours related to killed oral cholera vaccines (kOCVs) in August 2021, April 2022 and April 2023, approximately 11, 19 and 30 months postvaccination. …”
Get full text
Article -
1155
-
1156
-
1157
-
1158
-
1159
-
1160
Association of Chlamydia trachomatis infection with cervical atypia in adolescent women with short-term or long-term use of oral contraceptives: a longitudinal study in HPV vaccinated women
Published 2022-06-01“…On additive scale, the observed relative excess risk from interaction was 1.8.Conclusion The risk of SIL in HPV vaccinated women is significantly increased if they are C. trachomatis positive and have used OC for 5 or more years. …”
Get full text
Article